\n<\/p>\n
The Switzerland stock market ended on a strong note on Thursday amid continued optimism about global economic recovery despite rising coronavirus<\/span> cases and slow vaccination drive in several places across the world.<\/p>\n The benchmark SMI ended with a gain of 78.70 points or 0.71% at 11,206.88, the day’s high.<\/p>\n Partners Group shares gained nearly 2%. Givaudan climbed 1.7%, Roche Holding gained 1.65% and Alcon gained 1.57%. Nestle and SGS moved up by 1.2% and 1.1%, respectively.<\/p>\n ABB gained about 0.75% after launching a new share buyback program. Lonza Group, Sika and Novartis posted modest gains.<\/p>\n Swiss Life Holding, Zurich Insurance Group, Swatch Group and LafargeHolcim closed lower by 0.6 to 1%.<\/p>\n In the Mid Price Section, Lindt & Spruengli surged up 3.7% and Tecan Group gained 3.1%, while Straumann Holding, SIG Combibloc, VAT Group, Galenica Sante, Logitech and Temenos Group gained 1.3 to 2%.<\/p>\n Adecco, Barry Callebaut and Kuehne & Nagel also ended notably higher.<\/p>\n Among the losers, Dufry ended lower by about 3.3%, AMS shed nearly 2% and OC Oerlikon Corp lost 1.6%. Clariant, BB Biotech, Helvetia and Vifor Pharma ended down 0.9 to 1.1%.<\/p>\n Data released by Swiss National Bank showed foreign exchange reserves in Switzerland increased to CHF 930.48 billion in March from CHF 914.21 billion in February of 2021. <\/p>\n<\/p>\n Market Analysis<\/p>\n<\/div>\n